PT97749A - Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral

Info

Publication number
PT97749A
PT97749A PT97749A PT9774991A PT97749A PT 97749 A PT97749 A PT 97749A PT 97749 A PT97749 A PT 97749A PT 9774991 A PT9774991 A PT 9774991A PT 97749 A PT97749 A PT 97749A
Authority
PT
Portugal
Prior art keywords
dsarn
diagnosis
preparation
treatment
pharmaceutical compositions
Prior art date
Application number
PT97749A
Other languages
English (en)
Other versions
PT97749B (pt
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of PT97749A publication Critical patent/PT97749A/pt
Publication of PT97749B publication Critical patent/PT97749B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT97749A 1990-05-25 1991-05-23 Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral PT97749B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/528,962 US5132292A (en) 1990-05-25 1990-05-25 Treatment of viral hepatitis

Publications (2)

Publication Number Publication Date
PT97749A true PT97749A (pt) 1992-02-28
PT97749B PT97749B (pt) 1998-10-30

Family

ID=24107946

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97749A PT97749B (pt) 1990-05-25 1991-05-23 Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral

Country Status (13)

Country Link
US (1) US5132292A (pt)
EP (1) EP0531365A4 (pt)
JP (1) JP3208138B2 (pt)
CN (1) CN1059659A (pt)
AU (1) AU646050B2 (pt)
CA (1) CA2083603A1 (pt)
FI (1) FI925261A7 (pt)
HU (1) HUT65385A (pt)
IE (1) IE911782A1 (pt)
NZ (1) NZ238169A (pt)
PT (1) PT97749B (pt)
WO (1) WO1991018611A1 (pt)
ZA (1) ZA913949B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906980A (en) * 1987-07-17 1999-05-25 Hem Research Inc. Treatment of hepatitis with mismatched dsRNA
US5712257A (en) * 1987-08-12 1998-01-27 Hem Research, Inc. Topically active compositions of mismatched dsRNAs
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
US6521601B1 (en) * 1992-04-14 2003-02-18 Signal Pharmaceuticals, Inc. Method and composition for inhibition of viral replication
US6291438B1 (en) 1993-02-24 2001-09-18 Jui H. Wang Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use
WO1994019012A2 (en) * 1993-02-24 1994-09-01 Wang Jui H Compositions and methods of application of reactive antiviral polymers
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
TW589189B (en) 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
WO2005009337A2 (en) * 2003-05-16 2005-02-03 Hemispherx Biopharma Treating severe acute respiratory syndrome
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
GB0314824D0 (en) 2003-06-25 2003-07-30 Design Blue Ltd Energy absorbing material
DE202005004135U1 (de) * 2005-03-11 2005-05-19 Klocke Verpackungs-Service Gmbh Mehrkomponentenverpackung mit Applikator
AU2006322073A1 (en) * 2005-12-07 2007-06-14 Hemispherx Biopharma, Inc. dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931397A (en) * 1971-11-05 1976-01-06 Beecham Group Limited Biologically active material
US4283393A (en) * 1979-03-13 1981-08-11 Merck & Co., Inc. Topical application of interferon inducers
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
AU1820588A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
DE3853755T2 (de) * 1987-09-04 1995-12-14 Hem Pharma Corp Diagnose von Mangelzuständen doppelsträngiger RNS.
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape

Also Published As

Publication number Publication date
ZA913949B (en) 1992-06-24
AU646050B2 (en) 1994-02-03
CA2083603A1 (en) 1991-11-26
JPH05507481A (ja) 1993-10-28
US5132292A (en) 1992-07-21
FI925261A0 (fi) 1992-11-19
HUT65385A (en) 1994-06-28
HU9203682D0 (en) 1993-04-28
JP3208138B2 (ja) 2001-09-10
CN1059659A (zh) 1992-03-25
FI925261L (fi) 1992-11-19
WO1991018611A1 (en) 1991-12-12
NZ238169A (en) 1997-07-27
EP0531365A4 (en) 1993-09-15
AU7879691A (en) 1991-12-31
EP0531365A1 (en) 1993-03-17
FI925261A7 (fi) 1992-11-19
IE911782A1 (en) 1991-12-04
PT97749B (pt) 1998-10-30

Similar Documents

Publication Publication Date Title
PT98944A (pt) Processo de preparacao de anticorpos alterados e de composicoes farmaceuticas para a prevencao e tratamento de infeccoes
PT87259A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 17-cetoesteroides apropriadas para o tratamento e a profilaxia de infeccoes retrovirais
ITMI931522A1 (it) Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv)
PT91731A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas
FI921875A7 (fi) Menetelmä lääkeaineina käyttökelpoisten bentsisotiatsoli- ja bentsisoksatsoli-3-karboksiamidien valmistamiseksi
BR8706496A (pt) Processo para preparacao de compostos e utilizacao
PT84737B (pt) Processo para a preparacao de derivados de n-(2'-aminofenil)-benzamida e de composicoes farmaceuticas contendo-os
PT88612A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um agente anti-calculo dental
PT97749A (pt) Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral
PT84790B (pt) Processo de preparacao de derivados de amino-tiazol e de amino-oxazole e de composicoes farmaceuticas contendo-os
PT88225A (pt) Processo para a preparacao de formulacoes farmaceuticas contendo di-hidropiridinas
FI912296A7 (fi) Menetelmä 1,1,1,2-tetrafluorikloorietaanin ja pentafluorietaanin valmistamiseksi
PT97621A (pt) Processo para a preparacao de vacinas contra o papilomavirus humano 18 (hpv 18)
FI913957A7 (fi) 6,7-dihydro-3-fenyyli-1,2-bentsisoksatsol-4(5H)-oneja ja -oleja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
PT95199A (pt) Processo para a preparacao de emulsoes de silicone do tipo de oleo-em-agua para o tratamento de materiais texteis
FI921562A7 (fi) Gem-difosfonihapot, menetelmä niiden valmistamiseksi ja farmaseuttiset koostumukset, jotka sisältävät niitä
PT87243A (pt) Process for the preparation of aliphatic carboxamides and of pharmaceutical compounds containing them
EE9400068A (et) Ravimsegud viirushepatiidi B (HBV) infektsiooni ja selle poolt p6hjustatud haiguste raviks ja nende valmistamise protsess
PT82765A (pt) Processo para a preparacao de factor supressor activante e de composicoes farmaceuticas para o tratamento de doencas auto-imines
FI905173A7 (fi) Diatsabisykloamiiniyhdisteet ja menetelmä niiden valmistamiseksi
PT91745A (pt) Processo para a preparacao de uma composicao contendo acidos da bilis uteis para o tratamento de infeccoes virais
PT92345A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados diterpenoides de labdano e derivados de pirimido(6,1-a)isoquinolina-4-ona
PT88420A (pt) Process for the preparation of pharmaceutical compositions containing 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil and a method for treating hepatitis virus infections by using said compositions
BR9610851A (pt) Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
NO178883C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat for behandling av tonsillitt

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911029

FG3A Patent granted, date of granting

Effective date: 19980706

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20090106